Jens Juul Holst (born 1 August 1945) is a Danish physician and physiologist. He is known for discovering and describing the hormone glucagon-like peptide-1 (GLP-1), a hormone in the gut that plays an important role in the onset and development of Type 2 diabetes.[1]

Jens Juul Holst
Born (1945-08-01) 1 August 1945 (age 78)
Copenhagen, Denmark
Alma materUniversity of Copenhagen
Scientific career
Fields
InstitutionsUniversity of Copenhagen

In 2020, he was awarded the Warren Alpert Foundation Prize along Daniel J. Drucker and Joel F. Habener.[2]

In 2021, he was awarded the Canada Gairdner International Award along Daniel J. Drucker, Joel F. Habener, and Mary-Claire King.[3] He was also awarded the Banting Medal by the American Diabetes Association (ADA).[4]

In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research along Daniel J. Drucker, Jeffrey M. Friedman, Joel F. Habener, and Svetlana Mojsov.[5] and also in 2024 he received the Tang Prize in the category of "Biopharmaceutical Science".[6]

References

edit
  1. ^ Singh G, Krauthamer M, Bjalme-Evans M (January 2022). "Wegovy (semaglutide): a new weight loss drug for chronic weight management". Journal of Investigative Medicine. 70 (1): 5–13. doi:10.1136/jim-2021-001952. PMC 8717485. PMID 34706925.
  2. ^ Prize Recipients | Warren Alpert Foundation Prize
  3. ^ "2021 Canada Gairdner Awards Recognize World-Renowned Scientists For Transformative Contributions To Research Impacting Human Health". 7 April 2021. Retrieved 13 December 2021.
  4. ^ "Exceptional Leaders in Diabetes Research, Prevention and Treatment to be Recognized at ADA's 81st Scientific Sessions" (PDF; 269 kB). diabetes.org. American Diabetes Association. 2021-03-08.
  5. ^ "Daniel J. Drucker, Jeffrey M. Friedman, Joel F. Habener, Jens Juul Holst, and Svetlana Mojsov, Princess of Asturias Award for Technical and Scientific Research 2024". Princess of Asturias Foundation. 5 June 2024.
  6. ^ Tang Prize 2024